Pippa Corrie

14.8k citations
176 papers · 4.8k indexed · h-index 35
Topics
CAR-T cell therapy research (44 papers)Cancer Immunotherapy and Biomarkers (40 papers)Melanoma and MAPK Pathways (39 papers)

In The Last Decade

Pippa Corrie

170 papers receiving 4.7k citations

Peers

Pippa Corrie
Comparison fields: 5 of 140
  • Oncology 3.0k
  • Molecular Biology 1.5k
  • Immunology 802
  • Surgery 742
  • Pulmonary and Respiratory Medicine 731
Replace K. Höffken with:
K. Höffken Germany
Sewa S. Legha United States
Agop Y. Bedikian United States
S.B. Kaye United Kingdom
Sanjiv S. Agarwala United States
Guido Bocci Italy
A. Dimitrios Colevas United States
Michael Millward Australia
Bert L. Lum United States
Stefan Suciu Belgium
Pippa Corrie relative to K. Höffken Germany K. Höffken's profile →
Citations per field
00.5×7.8×
K. Höffken · 1×
Citations per year

Countries citing papers authored by Pippa Corrie

Since Specialization
Citations

This map shows the geographic impact of Pippa Corrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pippa Corrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pippa Corrie more than expected).

Fields of papers citing papers by Pippa Corrie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pippa Corrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pippa Corrie. The network helps show where Pippa Corrie may publish in the future.

Co-authorship network of co-authors of Pippa Corrie

This figure shows the co-authorship network connecting the top 25 collaborators of Pippa Corrie. A scholar is included among the top collaborators of Pippa Corrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pippa Corrie. Pippa Corrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 24
5 0
6 70
7 22
8 36
9 165
10 28
11 7
12 23
13 10
14 123
15 10
16 2
17
A phase I/IIa study of IMCgp100: Partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma
3
18
A Phase I study of IMCgp100: durable responses with a novel first-in-class immunotherapy for advanced melanoma
1
19
IMCgp100: a novel bispecific biologic for the treatment of malignant melanoma.
2
20 39

About Pippa Corrie

Pippa Corrie is a scholar working on Oncology, Cancer Research and Immunology, having authored 176 papers that have together received 4.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (44 papers), Cancer Immunotherapy and Biomarkers (40 papers) and Melanoma and MAPK Pathways (39 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (802 citations) and Cancer Research (499 citations). Pippa Corrie has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Sarah J. Welsh, Juan W. Valle, Martin Gore, Paul Lorigan, Gary J. Doherty, N.H. Cox, Bristi Basu, Mark R. Middleton, Christine Parkinson and Paul Nathan. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026